Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Tubulin Inhibitor 6 | Tubulin inhibitor 6 is a tubulin inhibitor and an effective inhibitor of a variety of cancer cell lines. Synonyms: IHAP1; 2-Chloro-10-(4-Methoxybenzoyl)-10H-Phenothiazine; (2-Chloro-10H-Phenothiazin-10-Yl)(4-Methoxyphenyl)Methanone; Oprea1_789892. Grades: 98%. CAS No. 105925-39-1. Molecular formula: C20H14ClNO2S. Mole weight: 367.8. |  |
| 10-Methyl-7-(2-hydroxy-3-N-Boc-3-phenylpropionyl) Docetaxel | 10-Methyl-7-(2-hydroxy-3-N-Boc-3-phenylpropionyl) Docetaxel is a derivative of baccatin III (B101000), an inhibitor of tubulin disassembly in human cancer cells and also the synthetic precursor of Paclitaxel (P132500). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C58H72N2O18, Molecular Weight: 1085.19. US Biological Life Sciences. |  Worldwide |
| 1, 2, 3, 4-Tetra hydro-N- hydroxy-2- [ (1- methyl -1H-pyrrol-2-yl ) carbonyl ] -6-isoquinolinecarboxamid e | HDAC6 Inhibitor is a potent and selective inhibitor of HDAC6 that poorly blocks other HDAC enzymes. HDAC6 is a predominantly cytoplasmic enzyme that targets α-tubulin, cortactin, and heat shock protein 90, as well as other substrates. Group: Biochemicals. Grades: Highly Purified. CAS No. 1259296-46-2. Pack Sizes: 500ug, 1mg. Molecular Formula: C16H17N3O3, Molecular Weight: 299.32. US Biological Life Sciences. | Worldwide |
| 1-Bis(4-fluorophenyl)methyl Piperazine | 1-Bis(4-fluorophenyl)methyl Piperazine (Flumazenil EP Impurity A) is a chemical reagent used in the synthesis of novel tubulin polymerization inhibitors. Also used in the synthesis of novel benzhydrylpiperazine carboxamide derivatives. Impurity of F455200. Group: Biochemicals. Grades: Highly Purified. CAS No. 27469-60-9. Pack Sizes: 1g, 10 g. Molecular Formula: C17H18F2N2. US Biological Life Sciences. | Worldwide |
| 1-Bis(4-fluorophenyl)methyl Piperazine-d8 | 1-Bis(4-fluorophenyl)methyl Piperzaine-d8 is a labelled analogue of 1-Bis(4-fluorophenyl)methyl Piperzaine (B434875), which is a chemical reagent used in the synthesis of novel tubulin polymerization inhibitors. Also used in the synthesis of novel benzhydrylpiperazine carboxamide derivatives. Impurity of F455200. It is also an intermediate in synthesizing Flunarizine-d8 Dihydrochloride (F455202), which is a calcium channel blocker; fluorinated derivative of Cinnarizine. Vasodilator (cerebral and peripheral). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 2.5mg. Molecular Formula: C17H10D8F2N2. US Biological Life Sciences. | Worldwide |
| 1-Naphthohydroxamic acid | 1-Naphthohydroxamic acid (Compound 2) is a potent and selective HDAC8 inhibitor with an IC 50 of 14 μM. 1-Naphthohydroxamic acid is more selectively for HDAC8 than class I HDAC1 and class II HDAC6 (IC 50 >100 μM). 1-Naphthohydroxamic acid does not increase global histone H4 acetylation and also does not reduce total intracellular HDAC activity [1] [2].1-Naphthohydroxamic acid can induce tubulin acetylation [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 6953-61-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-130538. |  |
| 1-Naphthohydroxamic acid | 1-Naphthohydroxamic acid (Compound 2) is a potent and selective HDAC8 inhibitor with an IC50 of 14 μM. 1-Naphthohydroxamic acid is more selectively for HDAC8 than class I HDAC1 and class II HDAC6 (IC50 >100 μM). 1-Naphthohydroxamic acid does not increase global histone H4 acetylation and also does not reduce total intracellular HDAC activity.1-Naphthohydroxamic acid can induce tubulin acetylation. Uses: Designed for use in research and industrial production. Product Category: Inhibitors. CAS No. 6953-61-3. Molecular formula: C11H9NO2. Mole weight: 187.19. Purity: >98.0%(T). Product ID: ACM6953613. Alfa Chemistry ISO 9001:2015 Certified. |  |
| 2,2,3-Tribromopropanal | 2,2,3-Tribromopropanal is a versatile reagent that was used for the first time in the 1950s. It is used as a reagent in the Skraup-type synthesis of 3-bromoquinolin-6-ols. 2,2,3-Tribromopropanal is also used in the preparation of quinolinyloxyacetamide s, a novel class of tubulin polymerization inhibitors with fungicidal activity. Group: Biochemicals. Grades: Highly Purified. CAS No. 26944-17-2. Pack Sizes: 1g, 5g. Molecular Formula: C3H3Br3O, Molecular Weight: 294.77. US Biological Life Sciences. | Worldwide |
| 2,4,5-Trimethoxybenzaldehyde | 2,4,5-Trimethoxybenzaldehyde is used in the synthesis of stilbene and hydrostibene derivatives as potential anticancer agents, inhibiting tubulin. Also used in the synthesis of HIV-RT inhibitors. Group: Biochemicals. Alternative Names: 2, 4, 5-Trimethoxybenzalde hyde; 2, 4, 5-Trimethoxylbenzalde hyde; 3, 4, 6-Trimethoxybenzalde hyde; Asaraldehyde; Asaronaldehyde; Asarylaldehyde; Gazarin; NSC 89299. Grades: Highly Purified. CAS No. 4460-86-0. Pack Sizes: 5g. US Biological Life Sciences. | Worldwide |
| 2-Azetidinone | 2-Azetidinone are β-lactams which maintain potential for antibiotic activity. Potential to act as tubulin polymerization inhibitors. Group: Biochemicals. Grades: Highly Purified. CAS No. 930-21-2. Pack Sizes: 100mg, 250mg. Molecular Formula: C3H5NO, Molecular Weight: 71.08. US Biological Life Sciences. | Worldwide |
| 2-Fluoro-1,4-dimethoxybenzene | 2-Fluoro-1,4-dimethoxybenzene is used as a reagent to synthesize fluoro analogues of Phenstatin, a tubulin polymerization inhibitor that has potential use as an anticancer agent. Group: Biochemicals. Grades: Highly Purified. CAS No. 82830-49-7. Pack Sizes: 2.5g, 10g. Molecular Formula: C8H9FO2, Molecular Weight: 156.15. US Biological Life Sciences. | Worldwide |
| 2-Formyl-1,1'-biphenyl | 2-Formyl-1,1'-biphenyl is a reactant used in the preparation of imidazoquinoline derivatives, a class of microsomal prostaglandin E2 synthase-1 inhibitors. 2-Formyl-1,1'-biphenyl is also used in the preparation of phenoxybenzylamino carboline derivatives as potential antitumor drugs targeting α-tubulin. Group: Biochemicals. Alternative Names: 2-Formylbiphenyl; 2-Phenylbenzaldehyde; 2-Biphenylcarboxalde hyde; [1,1'-Biphenyl]-2-carboxaldehyde. Grades: Highly Purified. CAS No. 1203-68-5. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| 2-Formyl-1,1'-biphenyl-13C6 | 2-Formyl-1,1'-biphenyl-13C6 is a reactant used in the preparation of labelled imidazoquinoline derivatives, a class of microsomal prostaglandin E2 synthase-1 inhibitors. 2-Formyl-1,1'-biphenyl is also used in the preparation of phenoxybenzylamino carboline derivatives as potential antitumor drugs targeting α-tubulin. Group: Biochemicals. Alternative Names: 2-Formylbiphenyl-13C6; 2-Phenylbenzaldehyde-13C6; 2-Biphenylcarboxaldehyde-13C6; [1,1'-Biphenyl]-2-carboxaldehyde-13C6. Grades: Highly Purified. Pack Sizes: 2.5mg. US Biological Life Sciences. | Worldwide |
| 2-m-Hydroxy(benzoyl) Paclitaxel | 2-m-Hydroxy Paclitaxel is a metabolite of Paclitaxel (P132500), an antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. Group: Biochemicals. Grades: Highly Purified. CAS No. 132160-31-7. Pack Sizes: 2.5mg, 25mg. Molecular Formula: C47H51NO15, Molecular Weight: 869.91. US Biological Life Sciences. | Worldwide |
| 2-Nitro-3-pyridinol | 2-Nitro-3-pyridinol may be used in the synthesis of novel sulfonates that are potent inhibitors of cell proliferation and tubulin polymerization. It may also be used to prepare (aminoaryl) (benzyloxy)pyridines as potential antitumor agents. Group: Biochemicals. Grades: Highly Purified. CAS No. 15128-82-2. Pack Sizes: 5g, 25g. Molecular Formula: C5H4N2O3. US Biological Life Sciences. | Worldwide |
| 2'-O- (tert-Butyldimethylsilyl) paclitaxel 7-O-triflate | 2'-O- (tert-Butyldimethylsilyl) paclitaxel 7-O-triflate is an intermediate in the synthesis of 6α-Hydroxy Paclitaxel (H948890), the major human metabolite of Paclitaxel (P132500), an antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. Group: Biochemicals. Grades: Highly Purified. CAS No. 165065-01-0. Pack Sizes: 5mg, 50mg. Molecular Formula: C54H64F3NO16SSi, Molecular Weight: 1100.23. US Biological Life Sciences. | Worldwide |
| 3-Amino-4-methoxybenzoic Acid | 3-Amino-4-methoxybenzoic Acid is a general reactant/reagent used in the synthesis of VEGFR-2 inhibitors. Also used in the preparation of dihydroisoquinoline compounds as tubulin polymerization inhibitors. Group: Biochemicals. Grades: Highly Purified. CAS No. 2840-26-8. Pack Sizes: 5g, 10g. Molecular Formula: C8H9NO3, Molecular Weight: 167.16. US Biological Life Sciences. | Worldwide |
| 3-Bromo-4-methoxyaniline | 3-Bromo-4-methoxyaniline is an intermediate used to prepare triazole analogs of combretastatin A-4 as cytotoxic agents and inhibitors of tubulin. It is also used in the synthesis of (1, 2, 4-oxadiazolyl) biphenylcarbonyltetra hydrospiro [furo] indolepiperidine (SB-224289) as selective 5-HT1B receptor inverse agonist. Group: Biochemicals. Grades: Highly Purified. CAS No. 19056-41-8. Pack Sizes: 500mg, 1g. Molecular Formula: C7H8BrNO, Molecular Weight: 202.05. US Biological Life Sciences. | Worldwide |
| 3-Hydroxy-2-nitropyridine | 3-Hydroxy-2-nitropyridine. Uses: 3-hydroxy-2-nitropyridine may be used in the synthesis of novel sulfonates that are potent inhibitors of cell proliferation and tubulin polymerization. Additional or Alternative Names: 3-pyridinol, 2-nitro- 2-Nitro-3-pyridinol. Product Category: Solvents. CAS No. 15128-82-2. Molecular formula: C5H4N2O3. Mole weight: 140.1. IUPACName: 2-nitropyridin-3-ol. Canonical SMILES: OC1=CC=CN=C1[N+]([O-])=O. Density: 1.5±0.1 g/cm3. ECNumber: 239-191-2. Product ID: ACM15128822. Alfa Chemistry ISO 9001:2015 Certified. | |
| 7-O-(Triethylsilyl)-2-O-tert-butyl(dimethyl)silyl Paclitaxel | Protected Paclitaxel. An antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. Group: Biochemicals. Alternative Names: (αR, βS)- β - (Benzoylamino) -α -[[ (1, 1-dimethylethyl) dimethylsilyl]oxy]-benzenepropanoic Acid (2aR, 4S, 4aS, 6R, 9S, 11S, 12S, 12aR, 12bS)-6, 12b-Bis(acetyloxy)-12-(benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-11-hydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-4-[(triethylsilyl)oxy]-7, 11-methano-1H-cyclodeca[3, 4]benz[1, 2-b]oxet-9-yl Ester. Grades: Highly Purified. CAS No. 156413-61-5. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| ADC Control Human IgG1-vcMMAE | ADC Control Human IgG1-vcMMAE is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-vcMMAE and can inhibit tubulin polymerization. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is vcMMAE (HY-15575)[1]. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg. Product ID: HY-164153. | |
| ADC Control Human IgG1-vcMMAF | ADC Control Human IgG1-vcMMAF is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-vcMMAF and can inhibit tubulin polymerization. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is MC-Val-Cit-PAB-MMAF (vcMMAF; HY-112786)[1]. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-164154. | |
| ALB-109564 | ALB 109564(a) is a semi-synthetic derivative of the vinka alkaloid vinblastine with potential antineoplastic activity. Tubulin inhibitor ALB 109564(a) binds to tubulin monomers and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the G2/M phase of the cell cycle. Synonyms: ALB-109564; ALB 109564; ALB109564; ALB 109564(a); Vincaleukoblastine, 12'-(methylthio)-, hydrochloride (1:2). CAS No. 854756-74-4. Molecular formula: C47H60N4O9S. Mole weight: 857.07. | |
| ALB 109564(a) dihydrochloride | ALB 109564(a) is a Tubulin inhibitor as a semi-synthetic derivative of the vinka alkaloid originated by AMRI. It can bind to tubulin monomers and inhibit microtubule formation, this leads to the disruption of mitotic spindle assembly and arrest of tumor cells in the G2/M phase of the cell cycle. Phase I clinical trials for Solid tumours is on going. Uses: Solid tumours. Synonyms: ALB-109564 dihydrochloride; ALB 109564 dihydrochloride; ALB109564 dihydrochloride; Vincaleukoblastine 12(methylthio) hydrochloride (1:2);(3aR,3a1R,4R,5S,5aR,10bR)-methyl 4-acetoxy-3a-ethyl-9-((3S,5S,7S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-13-(methylthio)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate. Grades: 98%. CAS No. 1300114-12-8. Molecular formula: C47H60N4O9S. Mole weight: 930.00. | |
| Albendazole oxide | Albendazole Oxide is a tubulin polymerization or assembly inhibitor. It can be used for livestock and poultry nematode disease, tapeworm disease and trematodiasis. Synonyms: Albendazole Impurity B; Ricobendazole; RS 8852; RS-8852; RS8852. Grades: >98%. CAS No. 54029-12-8. Molecular formula: C12H15N3O3S. Mole weight: 281.33. | |
| Antiproliferative agent-14 | Antiproliferative agent-14 (compound 3b) a potent tubulin polymerization inhibitor, with an IC 50 of 3.41 μM. Antiproliferative agent-14 has excellent antiproliferative activity. Antiproliferative agent-14 possess the ability to arrest cells at G2/M phases of the cell cycle [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1885900-35-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-148265. | |
| AR-42 | AR-42 (HDAC-42; OSU-HDAC42) is a potent, orally bioavailable pan- HDAC inhibitor ( IC 50 =16 nM). AR-42 induces growth inhibition, cell-cycle arrest, apoptosis , and activation of caspases-3/7. AR-42 promotes hyperacetylation of H3, H4, and alpha-tubulin, and up-regulation of p21. AR-42 shows cytotoxicity against various human cancer cell lines [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: HDAC-42; OSU-HDAC42. CAS No. 935881-37-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13265. | |
| BAL27862 | BAL27862 is a novel synthetic potent inhibitor of tubulin polymerization that induces cancer cell death. BAL27862 is a novel microtubule-destabilizing drug that is currently undergoing phase I clinical evaluation as the prodrug BAL101553. Synonyms: Avanbulin; BAL-27862; BAL 27862. Grades: 98%. CAS No. 798577-91-0. Molecular formula: C20H17N7O2. Mole weight: 387.40. | |
| Belantamab | Belantamab (GSK2857916) is a humanized IgG1 anti-BCMA/TNFRSF17 monoclonal antibody. Belantamab is linked to MMAF (HY-15579) through a non-cleavable ADC linker to synthesize the antibody-active molecule conjugate (ADC) Belantamab mafodotin (HY-P3239). After binding to BCMA on the surface of tumor cells, Belantamab mafodotin enters the cell through receptor-mediated endocytosis. After entering the cell, Belantamab mafodotin releases MMAF, blocks cell division by inhibiting tubulin polymerization, arrests the cell cycle and induces cell apoptosis. Belantamab can be used for the study of multiple myeloma, especially relapsed/refractory multiple myeloma [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: GSK2857914. CAS No. 2061894-48-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9980. | |
| Bi-Mc-VC-PAB-MMAE | Bi-Mc-VC-PAB-MMAE consists ADCs linker (Bi-Mc-Val-Cit-PAB) and potent tubulin inhibitor (MMAE, HY-15162). Bi-Mc-VC-PAB-MMAE is a drug-linker conjugate for ADC. Uses: Scientific research. Group: Signaling pathways. CAS No. 1620837-70-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-141833. | |
| BNC-105 | BNC105 is a novel compound being developed by Bionomics as a Vascular Disrupting Agent (VDA) for treatment of cancer. VDAs are drugs that disrupt the blood vessels that nourish tumours. BNC105 acts as a tubulin polymerization inhibitor and displays 80-fold higher potency against endothelial cells than that of CA4P. CA4P is a VDA currently under evaluation in phase III clinical trials. BNC105 is more potent and offers a wider therapeutic window. CA4P produces 90% vascular disruption at its no observed adverse event level (NOAEL), whereas BNC105 causes 95% vascular disruption at 1/8th of its NOAEL. Tissue distribution analysis of BNC105 in tumor-bearing mice showed that while the drug is cleared from all tissues 24 hours after administration, it is still present at high concentrations within the solid tumor mass. Furthermore, BNC105 treatment causes tumor regressions with complete tumor clearance in 20% of treated animals. Synonyms: BCN-105; BCN105; BCN 105. CAS No. 945771-74-4. Molecular formula: C20H20O7. Mole weight: 372.373. | |
| BNC-105 | BNC105 is a novel compound being developed by Bionomics as a Vascular Disrupting Agent (VDA) for treatment of cancer. VDAs are drugs that disrupt the blood vessels that nourish tumours. BNC105 acts as a tubulin polymerization inhibitor and displays 80-fold higher potency against endothelial cells than that of CA4P. CA4P is a VDA currently under evaluation in phase III clinical trials. BNC105 is more potent and offers a wider therapeutic window. CA4P produces 90% vascular disruption at its no observed adverse event level (NOAEL), whereas BNC105 causes 95% vascular disruption at 1/8th of its NOAEL. Tissue distribution analysis of BNC105 in tumor-bearing mice showed that while the drug is cleared from all tissues 24 hours after administration, it is still present at high concentrations within the solid tumor mass. Furthermore, BNC105 treatment causes tumor regressions with complete tumor clearance in 20% of treated animals. Uses: Designed for use in research and industrial production. Additional or Alternative Names: BCN105; BCN-105; BCN 105. Product Category: Inhibitors. Appearance: Beige fluffy powder. CAS No. 945771-74-4. Molecular formula: C20H20O7. Mole weight: 372.37. Purity: >98%. IUPACName: (7-hydroxy-6-methoxy-2-methylbenzofuran-3-yl)(3,4,5-trimethoxyphenyl)methanone. Canonical SMILES: O=C(C1=C(C)OC2=C(O)C(OC)=CC=C12)C3=CC(OC)=C(OC)C(OC)=C3. Product ID: ACM945771744. Alfa Chemistry ISO 9001:2015 Certified. Categories: BC | |
| Cevipabulin succinate | Cevipabulin is a Tubulin polymerisation inhibitor. It can bind to tubulin at the vinca site and promote the polymerization of tubulin into microtubules. Cevipabulin can stabilize tubulin and inhibit microtubule disassembly. This leads to cell cycle arrest at the G2/M phase. Phase I clinical trials for the treatment of solid tumor were discontinued. Uses: Solid tumours. Synonyms: TTI237; TTI 237; TTI-237; D06576; D 06576; D-06576; 5-chloro-6-(2,6-difluoro-4-(3-(methylamino)propoxy)phenyl)-N-((1S)-2,2,2-trifluoro-1-methylethyl)(1,2,4)triazolo(1,5-a)pyrimidin-7-amine (1:1), dihydrate. Grades: 98%. CAS No. 852954-81-5. Molecular formula: C18H18ClF5N6O. Mole weight: 618.94. | |
| CG200745 | CG200745 is a novel hydroxamate-based pan-histone deacetylase inhibitor (HDACI). Like other inhibitors, CG200745 has the hydroxamic acid moiety to bind zinc at the bottom of catalytic pocket. CG200745 inhibited deacetylation of histone H3 and tubulin as much as vorinostat and belinostat did. CG200745 also inhibited growth of prostate cancer cells, increased sub-G1 population, and activated caspase-9, -3 and -8 in LNCaP, DU145 and PC3 cells. These results indicate that CG200745 induces apoptosis. The preclinical results show that combination treatment with docetaxel and new HDACI, CG200745, potentiated anti-tumor effect in hormone-refractory prostate cancer (HRPC) cells via activation of apoptosis. Synonyms: Ivaltinostat; CG-200745; CG-2; (E)-N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalen-1-yloxy)methyl)oct-2-enediamide. CAS No. 936221-33-9. Molecular formula: C24H33N3O4. Mole weight: 427.55. | |
| cis-Trismethoxy resveratrol | Cis-trismethoxy resveratrol is a potent anti-mitotic reagent.Cis-trismethoxy resveratrol inhibits tubulin polymerization with an IC50 value of 4 μM. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 1,3-DIMETHOXY-5-[(1Z)-2-(4-METHOXYPHENYL)ETHENYL]-BENZENE;CIS-TRIMETHOXY STILBENE;CIS-TRISMETHOXY RESVERATROL;(Z)-3,5,4'-Trimethoxystilbene. Product Category: Inhibitors. Appearance: A solution in ethanol. CAS No. 94608-23-8. Molecular formula: C17H18O3. Mole weight: 270.32. Purity: 0.96. IUPACName: cis-trismethoxy Resveratrol. Canonical SMILES: COC1=CC(/C=C\C2=CC=C(C=C2)OC)=CC(OC)=C1. Density: 1.105g/cm³. Product ID: ACM94608238. Alfa Chemistry ISO 9001:2015 Certified. | |
| CKD-516 | This active molecular is a tubulin polymerisation inhibitor which is applicated for solid cancer treatment. CKD-516 disruptes tubulin of the endothelial cytoskeleton selectively. In Jun 2012, a South Korea company, Chong Kun Dang initiated enrolment in a phase I trial for solid tumours treatment in South Korea. In Dec 2014, Phase-I clinical trials in Solid tumours in South Korea was on going. Uses: Solid tumours. Synonyms: CKD-516 HCl; CKD 516 HCl; CKD516 HCl; (2S)-2-amino-3-methyl-N-[4-[3-(1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl]-1,3-thiazol-2-yl]butanamide;hydrochloride;1188371-47-2 (free base). Grades: 98%. CAS No. 1188371-47-2. Molecular formula: C26H28N6O5S. Mole weight: 536.6. | |
| CKD-516 HCl | CKD-516 is tubulin inhibitor for solid cancer, which was initiated phase 1 trial in Korea in 2010. CKD-516 selectively disrupted tubulin component of the endothelial cytoskeleton. Serial DCE-MRI showed a significant decrease in K-trans and IAUGC parameters from baseline at 4 h (39.9 % in K-trans; -45.0 % in IAUGC) and at 24 h (-32.2 % in K-trans; -36.5 % in IAUGC), and a significant recovery at 48 h (22.9 % in K-trans; 34.8 % in IAUGC) following administration of CKD-516 at a 0.7-mg/kg dose. When the tumors were stratified according to the initial K-trans value of 0.1, tumors with a high K-trans?>?0.1 which was indicative of having well-developed pre-existing vessels, showed greater reduction in K-trans and IAUGC values. On histologic examination, the degree of necrosis of treated tumors was significantly greater than that of untreated tumors. In summary, CKD-516 is an effective VDA which results in rapid vascular shutdown by targeting the tubulin component of tumor vessels and thus leads to necrosis. Synonyms: Valecobulin hydrochloride; CKD516 hydrochloride; CKD 516 hydrochloride. CAS No. 1240321-53-2. Molecular formula: C26H29ClN6O5S. Mole weight: 573.07. | |
| CMPD-1 | CMPD-1, also called MK2a Inhibitor, inhibits tubulin polymerisation. It inhibit p38α-mediated MK2a phosphorylation (apparent Ki = 330 nM). Synonyms: CMPD1; CMPD-1; CMPD 1; IN1225; IN-1225; IN 1225; 4-[4-(2-fluorophenyl)phenyl]-N-(4-hydroxyphenyl)butanamide; MK2a Inhibitor; MAPKAPK2a Inhibitor; CMPD1; CHEMBL235658; 41179-33-3; IN1225; 4-(2' -Fluorobiphenyl-4-yl)-N-(4-hydroxyphenyl)-butyramide; Mitogen-activated protein kinase-activated protein kinase 2a Inhibitor; MK2a Inhibitor_x000D_; SCHEMBL169905. CAS No. 41179-33-3. Molecular formula: C22H20FNO2. Mole weight: 349.4. | |
| Colchicine | Colchicine, an orally active alkaloid, is a potent tubulin inhibitor and a microtubule disrupting agent. Colchicine inhibits microtubule polymerization with an IC 50 of 3 nM. Colchicine is also a competitive antagonist of the α3 glycine receptors (GlyRs). Colchicine prevents non-steroidal anti-inflammatory drug (NSAID)-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome. Colchicine has extensive anti-inflammatory, immunosuppressive and strong anti-fibrosis effects and has the potential for gouty arthritis research [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Natural products. CAS No. 64-86-8. Pack Sizes: 10 mM * 1 mL; 100 mg; 200 mg; 500 mg. Product ID: HY-16569. | |
| Combretastatin | Combretastatin is a dihydrostilbenoid that found in Combretum caffrum. Members of the combretastatin family shows varying ability to cause vascular disruption in tumors. Combretastatin can bind to the β-subunit of tubulin. It is a tubulin polymerisation inhibitor and can be used for the treatment of tumor. Uses: Tumor. Synonyms: COMBRETASTATIN;(R)-(-)-Combretastatin;(R)-3-Hydroxy-4-methoxy-α-(3,4,5-trimethoxyphenyl)benzeneethanol;2-Methoxy-5-[(βR)-β-hydroxy-3,4,5-trimethoxyphenethyl]phenol;5-[(R)-2-Hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol. Grades: 95%. CAS No. 82855-09-2. Molecular formula: C18H22O6. Mole weight: 337.37. | |
| Combretastatin A-1 | Combretastatin A-1 is a microtubule polymerization inhibitor that binds to the colchicine-binding site of tubulin. Combretastatin A-1 inhibits the Wnt/β-catenin pathway through tubulin depolymerization mediated AKT deactivation. Combretastatin A-1 exhibits anti-tumor and anti-vascular effects [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 109971-63-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-121993. | |
| Crolibulin | Crolibulin, also known as EPC2407 and crinobulin, is a small molecule tubulin polymerization inhibitor with potential antineoplastic activity. Microtubulin inhibitor EPC2407 binds to the colchicine-binding site on beta-tubulin and inhibits the polymerization of tubulin into microtubules, which may result in cell cycle arrest, the induction of apoptosis, and the inhibition of tumor cell proliferation. As a vascular disruption agent (VDA), this agent also disrupts tumor neovascularization, which may result in a reduction in tumor blood flow and tumor hypoxia and ischemic necrosis. Synonyms: EPC2407; EPC 2407; EPC-2407; (R)-2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile. CAS No. 1000852-17-4. Molecular formula: C18H17BrN4O3. Mole weight: 417.263. | |
| CRT 0105950 | CRT 0105950 is a potent inhibitor of LIMK1/2 (IC50 = 0.3 and 1 nM at LIMK 1 and 2, respectively). It disrupts microtubule organization, inhibits phosphorylation of cofilin and increases α-tubulin acetylation in vitro. Synonyms: 4-[[5-[3-(2-Chloro-4-methylphenyl)-4-pyridinyl]-2-thiazolyl]amino]phenol. Grades: ≥98% by HPLC. CAS No. 1661845-86-8. Molecular formula: C21H16ClN3OS. Mole weight: 393.89. | |
| DBCO-PEG4-Val-Cit-PAB-MMAF | DBCO-PEG4-Val-Cit-PAB-MMAF consists a cleavable 4 unit PEG ADC linker (DBCO-PEG4-Val-Cit-PAB) and a potent tubulin polymerization inhibitor (MMAF). DBCO-PEG4-Val-Cit-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs)[1]. DBCO-PEG4-Val-Cit-PAB-MMAF is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Uses: Scientific research. Group: Signaling pathways. CAS No. 2244602-23-9. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-130990. | |
| DBCO-PEG4-VC-PAB-MMAE | DBCO-PEG4-VC-PAB-MMAE consists a ADC linker (DBCO-PEG4-VC-PAB) and a tubulin polymerization inhibitor MMAE (HY-15162). DBCO-PEG4-VC-PAB-MMAE can be used in the synthesis of antibody-agent conjugates (ADCs). MMAE is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. DBCO-PEG4-VC-PAB-MMAE is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Uses: Scientific research. Group: Signaling pathways. CAS No. 2129164-91-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-136314. | |
| DBCO-Val-Cit-PAB-MMAE | DBCO-Val-Cit-PAB-MMAE is a drug-linker conjugate, which can be used for the synthesis of ADC molecules. MMAE (HY-15162) is a tubulin inhibitor, which can be used as an ADC toxin. DBCO-Val-Cit-PAB is the linker with the electrophilic group [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2768446-73-5. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-W591408. | |
| Demecolcine | Demecolcine is a potent mitotic inhibitor with an IC 50 value of 2.4 μM for inhibition of tubulin polymerization. Colcemid (Demecolcine) can interact with tubulin dimers to induce anti-mitotic action and inhibit microtubule growth. Colcemid (Demecolcine) can be used for inflammatory disorders and cancer research [1] [2]. Uses: Scientific research. Group: Natural products. CAS No. 477-30-5. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg. Product ID: HY-N0282. | |
| DM3 | DM3 (Maytansinoid DM3) is a maytansine analog bearing disulfide or thiol groups and a tubulin inhibitor, and is a cytotoxic moiety of antibody-drug conjugates (ADCs) [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Maytansinoid DM3. CAS No. 796073-54-6. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg. Product ID: HY-130080. | |
| EHT-6706 dihydrochloride | EHT-6706 can target the colchicine-binding site to inhibit tubulin polymerization as a tubulin polymerisation inhibitor. It is under the development of Diaxonhit. EHT 6706 also is a vascular-disrupting agent. It can prevent endothelial cell tube formation and disrupt pre-established vessels, change the permeability of endothelial cell monolayers and inhibit endothelial cell migration. In Jul 2013, preclincal development for treatment of cancer was ongoing in the USA. Uses: Cancer. Synonyms: EHT-6706 dihydrochloride; EHT 6706 dihydrochloride; EHT6706 dihydrochloride; 7-ethoxy-4-(3,4,5-trimethoxybenzyl)isoquinolin-8-amine dihydrochloride. Grades: 98%. CAS No. 1351592-09-0. Molecular formula: C21H26Cl2N2O4. Mole weight: 441.35. | |
| EL-102 | EL102, a HIF1α inhibitor, has been found to have potential effect in restraining polymerisation of tubulin and influencing the stability of microtubule. IC50: 20-40 nM. Uses: El102 is a hif1α inhibitor that has been found to have potential effect in restraining polymerisation of tubulin and influencing the stability of microtubule. Synonyms: EL 102; EL102. Grades: 95%. CAS No. 1233948-61-2. Molecular formula: C19H16N2O3S2. Mole weight: 384.47. | |
| Entasobulin | Entasobulin is a tubulin polymerization inhibitor with potential anticancer activity. Entasobulin is a indolizine-glyoxylamide based small molecule that demonstrate substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes. The in vitro cytotoxic effects have been demonstrated across a wide array of tumor types of various origins (e.g., breast, colon, uterine). Synonyms: Entasobulin; UNII-TB77GU6BFO; UNII TB77GU6BFO. CAS No. 501921-61-5. Molecular formula: C26H18ClN3O2. Mole weight: 439.89. | |
| Epothilone A | Epothilone A is a competitive inhibitor of the binding of [ 3 H] paclitaxel to tubulin polymers, with a K i of 0.6-1.4 μM. Uses: Scientific research. Group: Natural products. Alternative Names: Epo A. CAS No. 152044-53-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13503. | |
| EpoY | EpoY (SD-142) acts as an irreversible inhibitor of the brain's primary tubulin tyrosine carboxypeptidase (TCP), a complex formed by vasohibin-1 (VASH1) and the small vasohibin binding protein (SVBP). By inhibiting TCP with an IC 50 value of approximately 500 nM, EpoY effectively decreases levels of detyrosinated alpha-tubulin, which is crucial for microtubule dynamics and neuronal differentiation. This inhibition leads to significant differentiation defects and has been linked to underlying issues associated with cancer and cardiomyopathies. Uses: Scientific research. Group: Signaling pathways. Alternative Names: SD-142. CAS No. 245660-13-3. Pack Sizes: 1 mg; 5 mg. Product ID: HY-148542. | |
| Estramustine phosphate | Estramustine phosphate, an estradiol analog, is an orally active antimicrotubule chemotherapy agent. Estramustine phosphate depolymerises microtubules by binding to microtubule associated proteins (MAPs) and/or to tubulin. Estramustine phosphate can interfere mitosis, trigger cell death and induce apoptosis, which can be used for the research of cancer like prostate cancer. Uses: Designed for use in research and industrial production. Product Category: Inhibitors. CAS No. 4891-15-0. Molecular formula: C23H32Cl2NO6P. Mole weight: 520.38. Canonical SMILES: O=C(OC1=CC=C2[C@@]3([H])CC[C@]4(C)[C@@H](OP(O)(O)=O)CC[C@@]4([H])[C@]3([H])CCC2=C1)N(CCCl)CCCl. Product ID: ACM4891150. Alfa Chemistry ISO 9001:2015 Certified. | |
| FC-116 | FC-11 is a Tubulin inhibitor that effectively inhibits tumor growth in mice. FC-11 can also induce endoplasmic reticulum (ER) stress to generate excess reactive oxygen species (ROS), leading to mitochondrial damage, thereby promoting apoptosis in colorectal cancer (CRC) cells by targeting microtubules. FC-11 can be used in cancer research [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2417298-29-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg. Product ID: HY-155068. | |
| Fenbendazole-Amine Sulfoxide | Fenbendazole-Amine Sulfoxide is a highly effective inhibitor of the helminth-specific enzyme, fumarate reductas in Ascaris suum. Also, it inhibits the polymerization of tubulin into microtubules in vitro. Group: Biochemicals. Grades: Highly Purified. CAS No. 69489-26-5. Pack Sizes: 10mg, 25mg. Molecular Formula: C13H11N3OS, Molecular Weight: 257.31. US Biological Life Sciences. | Worldwide |
| Ferulenol | Prenylated 4-hydroxycoumarin. Anti-tumor compound. Cytotoxic. Stimulator of tubulin polymerisation in vitro. Inhibitor of colchicine binding to tubulin. Antitubercular antibiotic with potent antibacterial activity. Anti-coagulant, pro-haemorrhagic compound with higher activity than warfarin. Shows hepatocyte toxicity. Disrupts mitochondrial membrane potential. Source:Ferula communis. Group: Biochemicals. Grades: Highly Purified. CAS No. 6805-34-1. Pack Sizes: 1mg, 5mg, 10mg. Molecular Formula: C24H30O3. US Biological Life Sciences. | Worldwide |
| Glochidiol | Glochidiol is an orally active tubulin polymerization inhibitor with an IC50 of 2.76 μM. Glochidiol shows anti-cancer activity. Uses: Designed for use in research and industrial production. Product Category: Inhibitors. Appearance: Powder. CAS No. 6610-56-6. Molecular formula: C30H50O2. Mole weight: 442.7. Purity: 0.98. IUPACName: (1R,3aR,5aR,5bR,7aS,9R,11R,11aR,11bS,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-9,11-diol. Canonical SMILES: CC(=C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(C(CC(C5(C)C)O)O)C)C)C. Product ID: ACM6610566. Alfa Chemistry ISO 9001:2015 Certified. Categories: Glochidion marianum. | |
| Gly3-VC-PAB-MMAE | Gly3-VC-PAB-MMAE consists a cleavable ADC linker (Gly3-VC-PAB) and a potent tubulin inhibitor (MMAE). Gly3-VC-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs)[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2684216-48-4. Pack Sizes: 5 mg; 10 mg. Product ID: HY-131056. | |
| GM-90257 | GM-90257 is a microtubule acetylation inhibitor. GM-90257 binds directly to ?-tubulin. GM-90257 prevents the recruitment of ?-tubulin acetyltransferase 1 (?TAT1) to the K40 residue in ?-tubulin. GM-90257 causes Apoptosis, downregulates BCl-2, and activates JNK and PARP. GM-90257 has anticancer activity against breast cancer[1][2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 315703-81-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-155956. | |
| HDAC Inhibitor XXIII, Tubastatin A (N-Hydroxy-4-(2-methyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-ylmethyl)benzamide, HCl) | A cell-permeable carbazolohydroxamate compound that acts as a highly potent, reversible and active-site zinc-binding HDAC6 inhibitor with excellent selectivity among other HDAC isozymes (IC50=0.015, 0.854, 16.4uM for HDAC6, HDAC8 and HDAC1, respectively) with no activity towards HDAC2, 3, 4, 7, 9, 10 and 11 (IC50>30uM). Shown to induce a-tubulin hyperacetylation at 2.5uM, and offer complete neuroprotection in primary cortical rat neuronal cells against homocysteic acid (HCA)-induced oxidative stress at 10uM with no noticeable neurotoxicity. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| HMN-176 | HMN-176 is an active metabolite of the synthetic antitumor compound HMN-214. HMN-176 shows potent cytotoxicity toward various human tumor cell lines, and in mitotic cells, it causes cell cycle arrest at M phase through the destruction of spindle polar bodies, followed by the induction of DNA fragmentation. However, no direct interactions of HMN-176 with tubulin are observed. Moreover, in animal models, it was observed that oral administration of the prodrug HMN-214 caused no significant nerve toxicity, a severe side effect often associated with microtubule binding agents such as Taxol and VCR.3 In Phase I clinical trials, HMN-214 has caused sensory neuropathy and ileus in some patients. However, the grade and frequency of these adverse effects were much lower than those of typical microtubule binding agents. As expected from the mechanism of action of HMN-214 (induction of G2-M arrest in dividing cells), the main adverse effect was neutropenia. (Source: CANCER RESEARCH 63, 6942 -6947). Uses: Designed for use in research and industrial production. Additional or Alternative Names: HMN176; HMN 176; HMN-176. Product Category: Inhibitors. Appearance: Solid powder. CAS No. 173529-10-7. Molecular formula: C20H18N2O4S. Mole weight: 382.43. Purity: >98%. IUPACName: (E)-4-(2-(4-methoxyphenylsulfonamido)styryl)pyridine 1-oxide. Canonical SMILES: O=S(NC1=CC=CC=C1/C=C/C2=CC=[N+]([O-])C=C2)(C3=CC=C(OC)C=C3)=O. Product ID: ACM173529107. Alfa Ch | |
| Indibulin | Indibulin (ZIO 301), an orally applicable inhibitor of tubulin assembly, shows potent anticancer activity with a minimal neurotoxicity. Indibulin reduces inter-kinetochoric tension, produces aberrant spindles, activates mitotic checkpoint proteins Mad2 and BubR1, and induces mitotic arrest and apoptosis [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: ZIO 301; D 24851. CAS No. 204205-90-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13649. | |
| IRC-083927 | IRC-083927 is novel and potent microtubule inhibitor with potential anticancer activity. IRC-083927 inhibits the tubulin polymerization by a binding to the colchicine site. IRC-083927 inhibits in vitro cell growth of human cancer cell lines in the low nanomolar range. More interesting, it remains highly active against cell lines resistant to microtubule-interacting agents (taxanes, Vinca alkaloids, or epothilones). Chronic oral treatment with IRC-083927 (5 mg/kg) inhibits the growth of two human tumor xenografts in nude mice (C33-A, human cervical cancer and MDA-MB-231, human hormone-independent breast cancer). Together, the antitumor effects induced by IRC-083927 on tumor models resistant to tubulin agents support further investigations to fully evaluate its potential for the treatment of advanced cancers, particularly those resistant to current clinically available drugs. Synonyms: IRC-083927; IRC 083927; IRC083927. Grades: 98%. CAS No. 955082-09-4. Molecular formula: C22H20ClFN4O4S. Mole weight: 490.93. | |
| ITSA1 | ITSA1 is a cell-permeable HDAC activator via inhibition of trichostatin A (TSA), which is a reversible inhibitor of HDAC. ITSA1 was showed to specifically counteract TSA-induced cell cycle arrest, histone acetylation, transcriptional activation, and cytoplasmic alpha-tubulin acetylation. Synonyms: ITSA-1; ITSA 1; N-(1H-Benzotriazol-1-yl)-2,4-dichlorobenzamide. Grades: ≥95%. CAS No. 200626-61-5. Molecular formula: C13H7Cl2N3O. Mole weight: 292.1. | |
| ITSA-1 (N-(1H-Benzotriazol-1-yl)-2,4-dichlorobenzamide, ITSA1) | Cell-permeable. ITSA-1 is a suppressor of Trichostatin A (TSA) and a molecular tool for dissecting gene regulation by distinct acetylation events (histone and tubulin). ITSA-1 specifically suppresses TSA inhibition of HDAC (histone deacetylase), but not other HDAC inhibitors. ITSA-1 reverses TSA induced histone acetylation, overall deacetylation. ITSA-1 also reverses TSA induced cell cycle arrest and apoptosis. Group: Biochemicals. Grades: Highly Purified. CAS No. 200626-61-5. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Ixabepilone | Ixabepilone (also known as azaepothilone B, or BMS-247550) is an orally bioavailable microtubule inhibitor. Ixabepilone was a semisynthetic analogue of epothilone B with antineoplastic activity. Ixabepilone binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arresting cells in the G2-M phase of the cell cycle and inducing tumor cell apoptosis. This agent demonstrates antineoplastic activity against taxane-resistant cell lines. Ixabepilone was approved in 2007. Synonyms: Azaepothilone B; BMS247550; BMS-247550; BMS 247550; Ixempra. Grades: >98%. CAS No. 219989-84-1. Molecular formula: C27H42N2O5S. Mole weight: 506.7. | |
| Ixabepilone | Ixabepilone (BMS-247550) is an orally bioavailable microtubule inhibitor, which binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arrests cells in the G2-M phase of the cell cycle and induces tumor cell apoptosis. Uses: Designed for use in research and industrial production. Additional or Alternative Names: IXABEPILONE;(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E) -1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-13-azabicyclo[14. 1.0]heptadecane-8,12-dione;Aza-epothilone B;Bms 247550-1;Ixempra;Ixempra kit;Unii-K27005np0a;Azi-epothilone B. Product Category: Inhibitors. Appearance: Solid. CAS No. 219989-84-1. Molecular formula: C27H42N2O5S. Mole weight: 506.7. Purity: 0.9984. Canonical SMILES: O=C([C@@H]([C@H]([C@H](CCC[C@]1(O[C@]1(C[C@H](N2)/C(C)=C/C3=CSC(C)=N3)[H])C)C)O)C)C(C)([C@H](CC2=O)O)C. Product ID: ACM219989841. Alfa Chemistry ISO 9001:2015 Certified. | |
| Ixabepilone | Ixabepilone (BMS-247550) is an orally bioavailable microtubule inhibitor, which binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arrests cells in the G2-M phase of the cell cycle and induces tumor cell apoptosis. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMS-247550; Aza-epothilone B. CAS No. 219989-84-1. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg. Product ID: HY-10222. | |
| Lexibulin | Lexibulin (CYT-997) is a potent and orally active tubulin polymerisation inhibitor with IC50s of 10-100 nM in cancer cell lines; with potent cytotoxic and vascular disrupting activity in vitro and in vivo [1] [2]. Lexibulin induces cell apoptosis and induces mitochondrial ROS generation in GC cells [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: CYT-997. CAS No. 917111-44-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-10498. | |
Our database is helping our users find suppliers everyday.
